Moreno, C., A. Aiello, R. Di Virgilio, V. Mazzotta, and A. Antinori. “Cost-Effectiveness Analysis of nirmatrelvir/Ritonavir in Adult Patients at High Risk of Progressing to Severe COVID-19”. Global and Regional Health Technology Assessment, vol. 11, no. 1, July 2025, pp. 168-76, doi:10.33393/grhta.2024.3403.